Company news

Annexon, Inc. news in 2021

Annexon, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Annexon Biosciences Announces Clinical and Preclinical Data Highlighting Potential of Complement-Targeting Programs at the 63rd ASH Annual Meeting & Exposition

December 12, 2021

Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results

November 8, 2021

Annexon Biosciences Further Strengthens Its Executive Leadership Team With Appointment of Ted Yednock, Ph.D., to Chief Innovation Officer and Appointment of Larry Mattheakis, Ph.D., as Chief Scientific Officer

October 3, 2021

Annexon Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year Business Update

August 15, 2021

Annexon Broadens Autoimmune Franchise with Advancement of Third Anti-C1q Product Candidate and Strategic Expansion into New Autoantibody-driven Diseases

July 21, 2021

Annexon Biosciences Provides Business Update and Reports First Quarter 2021 Financial Results

May 16, 2021

Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results with Recent Business Highlights

March 24, 2021

Annexon Advances Classical Complement Platform with Initiation of Global Phase 2 ARCHER Trial in Patients with Geographic Atrophy

February 28, 2021

Annexon Welcomes William H. Carson, M.D. to the Board of Directors

February 7, 2021

Decks in 2021